Tabuk Pharmaceutical Manufacturing Co.

نبذة عن شركة Tabuk Pharmaceutical Manufacturing Co.

Since its foundation in 1994, TABUK has passed several milestones in its journey towards becoming a successful player in the global generics pharmaceutical industry. Headquartered in Riyadh, Saudi Arabia, with GMP facilities in Tabuk city, the company has strong presence across the Middle East and North Africa (MENA) and a promising outlook in Eastern and Western Europe and the USA. TABUK has also established strong relations with Japanese companies, mainly in the field of in-licensing of unique products. TABUK is the 2nd largest local manufacturer in Saudi Arabia and the only company with European GMP and soon US FDA certified facilities. The facilities are divided into cephalosporin and non-cephalosporin areas. TABUK is amongst the few companies in the Middle East that can manufacture oral as well as sterile cephalosporin antibiotics. One of TABUK’s major assets is its Marketing, Sales and Distribution Network, which covers all the Middle East and North African countries. Through this network, TABUK has reached a leading position in the three segments (private, tenders and institutions) of a growing and increasingly competitive market. In the year 2002, TABUK sales of US$ 46 Million in Saudi Arabia have put the company at rank number 8 among major players in the Kingdom. Outside the MENA region, a number of TABUK’s products are under regulatory approvals in USA, UK, Italy, Spain, Portugal, France, Sweden, Poland, the Czech Republic, and Turkey. TABUK is continuously looking for opportunities in four strategic areas of: In-licensing of innovative/patented/differentiated products to produce/market in the Kingdom of Saudi Arabia/Middle East and North African countries. Sale of dossier/transfer of marketing authorization and supply of finished products to various European countries and the USA.